Document is current
Any future updates will be listed below
-
Authors
Öz, Gülin https://orcid.org/0000-0002-5769-183X
Cocozza, Sirio https://orcid.org/0000-0002-0300-5160
Rezende, Thiago J. R. https://orcid.org/0000-0001-8453-0313
Henry, Pierre-Gilles https://orcid.org/0000-0002-8270-1956
Faber, Jennifer
Harding, Ian H.
,
Accolla, Ettore A.
Adarmes-Gómez, Astrid
Alhusaini, Saud
Bando, Kyota
Boesch, Sylvia
Cossa, Antoine
Deistung, Andreas
D’Ostilio, Kevin
Ferreira, Monica
Franca, Marcondes C. Jr
Fuin, Niccolo
Gazdzinski, Stefan
Grisoli, Marina
Heidari, Morteza
Indelicato, Elisabetta
Joers, James M.
Kapteijns, Kirsten
Kinnunen, Kirsi M.
Kovacs, Norbert
Lenglet, Christophe
Makowska, Luiza
Mariotti, Caterina
Marvel, Cherie L.
Minnerop, Martina
Mochel, Fanny
Rangel, Deborah Moreira
Nachbauer, Wolfgang
Nigri, Anna
Nobre, Rui Jorge
O’Keefe, Joan A.
Pandolfo, Massimo
Ratai, Eva-Maria
Reetz, Kathrin
Rylski, Marcin
Santana, Magda M.
Sarro, Lidia
Sestakauskas, Kastytis
Thieme, Andreas
Timmann, Dagmar
Ying, Sarah H.
- License Information
-
More Information
Article History
Accepted: 1 May 2026
First Online: 3 June 2026
Competing interests
: G.Ö. has consulted for IXICO Technologies, Lacerta Therapeutics, Servier and UCB Biopharma; has served on the Scientific Advisory Board of BrainSpec and the Medical Research Advisory Board of the National Ataxia Foundation; and has received research support from Biogen. S.C. has consulted for TTLC; has served on the Scientific Advisory Board of Amicus Therapeutics; and has received research grants from Fondazione Italiana Sclerosi Multipla and Telethon. T.J.R.R. has consulted for and received research support from Biogen and PTC Therapeutics. P.-G.H. has received research support from Minoryx Therapeutics. J.F. has received consultancy honoraria from Vico Therapeutics, unrelated to the present manuscript. I.H.H. has consulted for Solid Biosciences and Steminent Biotherapeutics in the 12 months preceding manuscript submission.
Free to read: This content has been made available to all.
